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The treatment of lower limb tumors has been shifted by advancements in adjuvant treat-
ment protocols and microsurgical reconstruction from limb amputation to limb salvage. 
Standard approaches include oncological surgery by a multidisciplinary team in terms of 
limb sparing followed by soft tissue reconstruction and adjuvant therapy when indicated. 
For the development of a comprehensive surgical plan, the identity of the tumor should 
first be determined by histology after biopsy. Then the surgical goal and comprehen-
sive treatment concept should be developed by a multidisciplinary tumor board and 
combined with soft tissue reconstruction. In this article, plastic surgical reconstruction 
options for soft coverage of the lower extremity following oncological surgery will be 
described along with the five clinical cases.
Keywords: soft tissue sarcoma, bone sarcoma, limb-sparing surgery, modular endoprosthetic implantation, 
soft tissue reconstruction, microvascular flap
iNTRODUCTiON
Soft tissue tumors and bone sarcomas are a heterogeneous class of mesenchymal tumors com-
prising <1% of all malignancies in adults and represent 15% of pediatric malignancies1 (1). The 
overall mortality rate for soft and bone sarcomas was estimated as 30 and 45%, respectively1 (1). 
Two-thirds of the tumors are located in limbs, most frequently in the lower extremity (46%) (1). 
Osteosarcoma has been the primary model to base treatment of all sarcomas. Multi-agent chemo-
therapy regimens have demonstrated an increase in overall survival rates (15–20%) as compared 
to surgery alone in the 1970s, but more recently, survival has increased to 55–80%1 (2).
There has been considerable progress in the management of limb sarcomas over the past few 
decades. Several decades ago, there was a high rate of limb amputations (38–47%) associated with 
sarcoma, likely the result of reduced radiotherapy and reconstructive methods (3). The introduc-
tion of radiotherapy has considerably improved outcome and in combination with oncological 
and advanced reconstructive surgery important advances have been made in tumor control and 
functional limb preservation1 (4).
In high-grade malignancies or tumors of borderline resectability, preoperative chemo-
therapeutical downsizing could be indicated. In the case of non-resectable tumors, especially 
sarcomas in close proximity of functional structures, isolated limb perfusion can be considered 
(5). Postoperatively, necessary chemotherapy can be combined with deep wave hyperthermia 
(6). Although limb amputation may be unavoidable in some circumstances, the combination 
of limb-sparing and reconstructive surgery can optimize function of the affected limb and 
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avoid the significant psychological impact associated with 
amputation1. Endoprosthetic procedures for skeletal recon-
struction have improved functional outcome (7). Currently, 
90–95% of limb sarcoma patients may undergo successful 
limb-sparing procedures with soft tissue coverage when 
treated at a major center specializing in musculoskeletal 
oncology (4). Thus, for the majority of soft tissue malignan-
cies and bone sarcomas of the limb, limb-sparing surgery 
performed in an interdisciplinary team (8) is an important 
treatment option.
SURGiCAL PLANNiNG AND  
DeCiSiON-MAKiNG CONSiDeRATiONS
A meticulous surgical technique is crucial to ensure an optimal 
oncological and functional outcome for the patient. Successful 
limb-sparing surgery consists of three interdependent stages 
performed in sequence as follows:
 1. Tumor resection with appropriate oncological margins,
 2. Reconstruction and stabilization of the involved bone and 
joints, and
 3. Restoration of the soft tissue envelope and restoration of 
function.
The overall aim of oncological surgery followed by soft tissue 
reconstruction is to carry out a wide compartmental excision 
for maximal tumor removal, yet to preserve limb function. 
The excision is defined as wide when the distance between the 
histologically defined tumor and the excision margins are at 
least 2 cm (3). However, if there is an anatomical barrier such as 
deep or muscle fascia that is intact, which separates the tumor 
from the excision border, the tumor may be considered wide 
with an excision distance <2 cm (3). The European Society for 
Medical Oncology (ESMO) guideline does not state a specific 
margin size. However, it does recommend that radiation therapy 
can be used for tumors larger than 5  cm2,3. Because tumor 
excision often leads to potentially large tissue defects, includ-
ing bone, joint, and tendon exposure, reconstructive surgery 
is an important and critical element (9, 10). For skeletal and 
joint reconstruction, advances in commercial modular endo-
prosthetic devices have importantly advanced the field1 (7, 11). 
With the development of modular endoprosthetic devices with 
their large range in size and adaptability, the surgeon can focus 
on optimizing the oncological resection procedure, having the 
knowledge that appropriate prosthetic components will likely 
be available even if the surgical procedure needs to deviate from 
the preoperative plan. Thus, modern modular endoprosthetic 
reconstruction plays an important role in limb-sparing surgery 
for bone sarcoma resection. Ongoing work to develop better 
approaches for attachment of tendon to endoprosthetic devices 
such as novel clamps and in growth-promoting surfaces to 
2 www.esmo.org
3 www.current-oncology.com
promote may lead to improved junctional strength1 (11). The 
most common site for primary bone sarcomas is the distal 
femur. Endoprosthetic reconstruction of this region is of par-
ticular challenge because the cruciate and collateral ligaments 
must be removed thus reducing stability1 (12). Appropriate soft 
tissue coverage is imperative to decrease the risk of secondary 
periprosthetic infection.
After tumor resection of the lower extremity complex, defects 
are anticipated and multiple variables must be considered for soft 
tissue reconstruction. A large number of details must be taken 
into consideration when planning a reconstruction, especially 
after oncological surgery. One must consider the timing of 
reconstruction, size and location of the defect, involvement of 
neurovascular structures, and exposure or resection of bone, 
tendons, and nerves. Donor site morbidity, disease prognosis, 
and the patient’s previous level of function and expectations of 
restored function must be evaluated as well.
The reconstructive ladder as a concept for wound closure has 
gone through several adjustments over time (13–15). While the 
concept of using the simplest approach and moving up the ladder 
to more complex approaches is certainly important, there may be 
times with oncological defect surgery where this approach may 
not be valid (13).
This led to the idea of the “reconstructive elevator,” which 
was introduced by Gottlieb and Krieger (16). While still admit-
ting to the idea of increasing levels of complex difficulty, the 
“reconstructive elevator” offers the flexibility to elevate directly 
to an appropriate level of complexity as necessary (17). This 
concept draws attention to the importance of selecting the most 
appropriate level of reconstruction instead of selecting the least 
complex that is often the case in soft issue coverage after onco-
logical surgery.
DeTeRMiNiNG THe OPTiMAL TiMiNG 
FOR SOFT TiSSUe ReCONSTRUCTiON
It was demonstrated with regard to traumatic wound coverage of 
the lower limb that microvascular tissue transfer after 5–21 days 
post-trauma resulted in higher flap failure rates and wound infec-
tions (18). In soft tissue coverage following oncological surgery, 
an early time point for wound closure is preferred, but multiple 
stage/sequential procedure might be necessary for the achieve-
ment of a R0 resection and temporary closure is applicable. 
However, when there is R1 or R2 status and chemo- and radiation 
therapy is required, stable wound closure is essential before the 
onset of these therapeutic regimens.
There are several advantages for immediate reconstruction 
to be carried out at the time of tumor resection. One is that the 
anatomical perspective of the oncological defect can be assessed 
prior to scar formation. This will minimize surgical dissection 
of, for example, exposure of vessels for microvascular repair that 
would be necessitated if there was a delay with scar formation (19, 
20). Another advantage is the psychological benefit to the patient. 
However, reconstruction is delayed in cases where the margins of 
the resection site are not clear or when the patient has issues with 
would healing (20).
FiGURe 1 | Demonstration of tumor at the right inguinal region expanding on the proximal thigh (A), complete metastatic resection was performed 
with preservation of inguinal vessels and femoral nerve (B,C). As a next step, an extended VRAM flap from the contralateral side was prepared and 
transferred for defect closure (D,e). Long-term results revealed complete removal and stable coverage with minimal donor morbidity (F).
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SOFT TiSSUe ReCONSTRUCTiON
Plastic surgical reconstruction options for soft coverage of the 
lower extremity following oncological surgery will be described 
by means of five clinical cases.
Case 1
The first case describes the soft tissue coverage in the proximal 
thigh/inguinal region. A 55-year-old male patient presented 
with an ulcerating metachronous metastasis in the right inguinal 
region (Figure 1A) after resection of a squamous cell carcinoma 
(SCC) to the anus limited to the anal margin only infiltrating 
the perianal skin and without invasion of the sphincter muscle, 
which was resected 11  months before (pT1, pN0, pM0, R0). 
The surgical excision of the metachronous metastasis resulted 
in a soft tissue defect with an extension of 11 cm ×  11 cm as 
illustrated in Figures 1B,C. Here, the complete resection with 
preservation of vessels and femoral nerve followed by soft tissue 
coverage with an extended vertical rectus abdominis myocu-
taneous (VRAM) flap (Figures  1C–E). After wound healing, 
adjuvant chemotherapy with Cisplatin/5-Fluorouracil followed 
by radiotherapy was performed according to the anal cancer 
treatment protocols for metastatic diseases following current 
guidelines (21). Long-term follow-up demonstrated stable cov-
erage (Figure 1F). This case represents an individualized tumor 
treatment concept and a challenging situation for soft tissue 
coverage because of its large soft tissue defect in the groin with 
the need of a soon adjuvant therapy.
Treatment options for the groin and thigh reconstruction 
include as local flaps include sartorius, the tensor fascia latae, or 
the rectus femoris flaps. With regard to tumor size in the pre-
sented case, an extended VRAM flap was performed.
Case 2
A 54-year-old female patient presented with a gradually grow-
ing non-inflammatory and indolent tumor of the right thigh 
(Figures  2A,D). Magnetic resonance imaging (MRI) revealed 
a heterogeneous tumor involving the vastus lateralis, medialis, 
and intermedius muscles (Figures  2B,C). A biopsy confirmed 
an undifferentiated myxofibrosarcoma. CT scans showed no evi-
dence of metastasis. The tumor was removed with a complete size 
of the resected tissue of 15 cm × 8 cm × 7.5 cm under preservation 
of vessels and the femoral nerve (Figures 2E–G). Primary closure 
could be performed after radical resection and histology revealed 
an undifferentiated myxofibrosarcoma pT2b, pN0, pM0, R0; G3 
(FNCLCC). Clinical follow-up examination 1 year after surgical 
treatment showed stable long-term results with a range of motion 
of right knee for extension/flexion 0/0/120° and 60/0/40° of the 
right hip joint (Figures 2H–J).
Treatment options for the groin and thigh reconstruction 
include sartorius, tensor fascia latae, or rectus femoris local 
flaps (22). With regard to tumor size in the presented case 1, an 
extended VRAM flap was performed. In the illustrated case 2, 
the defect could be closed primarily. If primary closure cannot 
be performed, the use of local muscle is in most cases the best 
treatment option and the need for free flaps is only in extensive 
cases necessary. For anastomosis of a microvascular flap, the 
deep inferior epigastric, the superficial epigastric, the superficial 
circumflex iliac, or the femoral vessels could serve as recipient 
FiGURe 2 | Preoperative clinical presentation of a 54-year-old female with an undifferentiated myxofibrosarcoma G3 in the anterior compartment of 
ventral thigh and correlation with MRi (A–C). Intraoperative situs (C–F) with complete tumor removal (G). Long-term results (H–J) of primary closure showing 
the esthetic outcome and maintained function of the right limb.
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vessels where end to side anastomoses should be preferred to 
preserve distal blood flow (23).
Case 3
This case describes a 15-year-old female with confirmed osteo-
sarcoma of the proximal tibia and treatment with an induction 
chemotherapy according to the Cooperative German–Austrian–
Swiss Osteosarcoma Study Group (COSS) protocol (24, 25). After 
completing neoadjuvant therapy, the patient was scheduled for 
extraarticular knee joint resection. Modular endoprosthetic knee 
reconstruction was performed with a proximal tibia replacement 
and a knee reconstruction implant (MUTARS®) using a trevira 
tube for soft tissue fixation. Initial soft tissue coverage with a medial 
gastrocnemius flap failed due to early post-operative infection. 
After multiple debridement and revision surgery with antibiotic 
spacer application, infection was treated successfully. A new modu-
lar endoprosthetic replacement (Figures 3A–C) was then covered 
with a microvascular latissimus dorsi flap as limb salvage procedure 
(Figures 3B,D–F). Histology confirmed complete R0 resection of 
the osteosarcoma pT2, pN0, pM0; G3. The patient regained good 
post-operative function without signs of extension gap and long-
term stable soft tissue reconstruction (Figures 3D–F).
Local flap for soft tissue coverage at the knee, the gastrocne-
mius flap is the first choice (26). From the gastrocnemius muscle, 
either the medial or the lateral or both heads can be transferred 
for soft tissue coverage. Usually, the medial head is larger in 
comparison to the lateral gastrocnemius head. Other possibilities 
besides free flaps include a reversed anterior lateral thigh (ALT) 
flap or a reverse vastus lateralis flap. In flap decision-making for 
knee reconstruction, the range of motion of the knee as highly 
mobile joint has to be taken into consideration and the amount 
of necessary surface area has to be calculated carefully within the 
flap design (23).
Case 4
The next case describes a 51-year-old female patient with a gradu-
ally growing non-inflammatory and indolent swelling of her right 
lower leg. MRI showed a non-homogeneous tumor in the antero-
lateral compartment of right leg, within the tibialis anterior and 
the extensor digitorum longus muscles. CT scans of her abdomen 
and chest and other studies showed no evidence of metastasis. 
Biopsy confirmed the diagnosis of a sarcoma. Subsequently, 
complete tumor removal was performed (Figure 4A) leading to a 
soft tissue defect of 10 cm × 7 cm (Figure 4B). Wound closure was 
performed with a fasciocutaneous transposition combined with a 
small split thickness skin graft at the donor side (Figures 4C–F). 
Histologically, the tumor was graded as pleomorphic undiffer-
entiated sarcoma pT1, pN0, pM0, R0; G3. After wound healing, 
adjuvant radiotherapy with total dose of 56 Gy was conducted. 
Clinical follow-up 1 year after surgical treatment showed a stable 
complete soft tissue coverage with a range of motion for ankle 
dorsiflexion/plantar flexion of 5/0/30° and for eversion/inver-
sion of 5/0/20° on the operated right side in comparison to the 
unaffected left side for ankle dorsiflexion/plantar flexion with 
15/0/30° and eversion/inversion 10/0/20°.
Reconstruction options for the lower leg with regard to local 
flaps are limited particularly for the lower third can be challeng-
ing, thus free flaps are often required. Here, we performed as a 
prerequisite an angiography. Underlying stenosis of the arteries 
can often be diagnosed and the lower limb revascularization pre-
ceding surgical wound coverage is necessary to reduce complica-
tion rates. An algorithm was described to improve the success of 
microvascular tissue transfer on the lower extremity (27).
Case 5
An 81-year-old male patient presented with a previously 
incomplete (R1) resected primary SCC on the lateral aspect of 
FiGURe 4 | Defect of the lower leg after tumor removal (A) with remaining defect at the lateral side (B). A fasciocutaneous transposition flap is raised (C) 
and transferred ventrally into the defect (D). Full coverage can be achieved (e) and remaining areas at the donor side can be transplanted with split thickness skin 
graft (F).
FiGURe 3 | intraoperative situs with implanted tumor prosthesis (MUTARS®) after extraarticular tumor resection of the knee joint (A,B) and coverage 
with a microvascular latissimus dorsi flap (B). (C) shows the corresponding x-ray image with a proximal tibial replacement. Post-operative esthetic and 
functional outcome (D–F).
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his left ankle. X-ray examination revealed no involvement of 
the underlying bone and CT scans ruled out any further meta-
static involvement. Tumor resection of the SCC resulted in an 
extended soft tissue defect (Figures 5A,B) that required micro-
vascular flap coverage and preparation of an ipsilateral ALT flap 
with a size of 19  cm ×  9  cm was performed (Figures  5C–E). 
Histology confirmed complete tumor removal of the SCC (pTx, 
pN0, pM0, R0; G2). Complete wound closure could be achieved 
(Figure  5F) with long-term functional and esthetic outcome 
(Figure 5G).
FiGURe 5 | extensive soft tissue defect at the lateral malleolus (A) after tumor excision (B). For wound coverage, an ALT flap is prepared (C,D) with a long 
pedicle (e) for microvascular anastomosis. The ALT flap engrafted into the defect shows intraoperatively (F) and after wound healing a very satisfying result (G).
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Possibilities for local flaps at the foot include the reversed 
sural, dorsalis pedis, and abductor digiti minimi flaps. For free-
flap anastomosis, recipient vessels are the anterior, posterior, 
peroneal, and dorsalis pedis artery with concomitant veins. The 
plantar surface requires a separate approach of exposure to high 
pressure during walking and mechanical stress. Here, an instep 
flap could be used as an option (22).
POST-OPeRATive CARe AND 
iMMOBiLiZATiON
In the post-operative phase, the limb should be maximally 
elevated for swelling reduction that could potentially compro-
mise the flap used for soft tissue coverage1 (22). It is critical that 
the limb is immobilized and sterile dressing applied to maxi-
mize tissue survival (22, 28). The 24-h post-operative period 
is critical because a high incidence of complication related to 
micro-revascularization of the flap occurs (22, 28). Hematoma 
formation must be reduced and large-bore closed suction drains 
are helpful in this regard1 (22). In case of hematoma develop-
ment immediate and aggressive treatment in the operating 
room should be carried out to prevent occlusion/compression 
of microvascular anastomoses, which could lead to perfu-
sion complications of the flap as an immediate effect and the 
secondary effect of infection, especially in case of implanted 
endoprosthesis1 (22). Subsequent wound care, physical therapy, 
and potential tumor adjuvant therapy are essential to complete 
the therapeutic process (28). Completion of the therapy should 
include standard wound care and physical therapy with the 
potential for adjuvant therapy for tumor treatment (22, 28).
CONCLUSiON
Limb salvage in patients with sarcoma is possible with an accept-
able outcome by selective combination of required treatment 
modalities. Currently, primary amputation is usually only per-
formed in cases where the tumor infiltrates major neurovascular 
structures, bone or joint and when not even marginal resection 
is feasible. In these cases, the great risk of local recurrence or of 
poor limb function favored amputation. Clearly, it is important 
that patients should be provided with solutions that address 
improvement in function, but cosmetic and psychological 
issues should be addressed as well. For patients initially thought 
to have unsalvageable limbs because of tumor size and loca-
tion, reassessment after preoperative chemotherapy may allow 
reconsideration of limb-sparing procedures. Therefore, a careful 
re-evaluation of the patient following adjuvant treatment is nec-
essary for defining a meticulous multidisciplinary surgical plan. 
Limb-sparing procedures combined with soft tissue coverage 
after oncological surgery should not be limited to patients with 
a curative goal, patients in a palliative stage of disease can benefit 
from surgery in terms of pain reduction and improvement of 
quality of life. Finally, given the complexity of a multidiscipli-
nary approach, individualized treatment should be performed 
in major centers specializing in musculoskeletal oncology.
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